<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>696938ac-665c-483e-81c4-883e041f7536</id>
  <name>AHS OS N MULTI PCHS Alcohol Withdrawal Protocol Order Set</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~696938ac-665c-483e-81c4-883e041f7536~NAME~AHS OS N MULTI PCHS Alcohol Withdrawal Protocol Order Set}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;A patient specific order from the authorized prescriber is required to implement this protocol. This order authorizes the administration of medications and interventions within this Protocol. &amp;nbsp;&lt;br&gt;Early initiation of this protocol is encouraged to ensure that all patients benefit from the timely administration of medication to avoid progression of symptoms.&lt;br&gt;Alcohol withdrawal symptoms may not overtly be present upon initial assessment. Patient history and clinical judgment should always be used when initiating this Protocol.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;background-color:#f1c40f&quot;&gt;Put in new URL (create smart Link) - not availble till january 6&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Patients who have been initiated on medication including lorazepam tapering&lt;br&gt;shall finish the medication regime, even if monitoring has been discontinued&amp;nbsp;&lt;br&gt;unless otherwise ordered by an authorized prescriber.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;POCT Glucose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Once on initial assessment of alcohol withdrawal&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care Assessments&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Per protocol, Starting today at 14:04, Until Specified&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;u&gt;&lt;span style=&quot;background-color:#f1c40f&quot;&gt;If the CIWA-Ar score is less than or equal to 9&lt;/span&gt;&lt;/u&gt;, the health care professional shall consider the patient’s clinical presentation, medical history, and CIWA-Ar score to determine if they require monitoring and treatment overnight. &amp;nbsp;If the health care professional determines that monitoring and treatment is required overnight, and 24-hour staffing is not available, staffing in the current facility shall be augmented or the patient shall be transferred to another facility.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;u&gt;&lt;span style=&quot;background-color:#f1c40f&quot;&gt;If the CIWA-Ar score is equal or greater than 10 at any time &lt;/span&gt;&lt;/u&gt;and if 24-hour staffing is not available for monitoring and treatment, staffing in the current facility shall be augmented or the patient&lt;/p&gt;&lt;p&gt;shall be transferred to another facility.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Notify&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Notify MRHP when the patient&apos;s CIWA-Ar score is greater than 10 without clinical improvement after four (4) hours.&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;sodium chloride 0.9% bag&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;125 mL/hr, intravenous, continuous&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lactated Ringer&apos;s infusion&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;125 mL/hr, intravenous, continuous&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Patients who have been initiated on medication including lorazepam tapering&lt;br&gt;shall finish the medication regime, even if monitoring has been discontinued&amp;nbsp;&lt;br&gt;unless otherwise ordered by an authorized prescriber&lt;br&gt;&amp;nbsp;&lt;br&gt;Do not exceed a maximum dose of lorazepam 16 mg in 24 hours from all sources.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;CIWA-Ar Score is Greater than or equal to 10&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Begin Lorazepam taper as follows:&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;CIWA-Ar Score is Greater than or equal to 10&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;In addition to Lorazepam taper:&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Do not exceed a maximum dose of lorazepam 16 mg in 24 hours from all sources.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;CIWA-Ar Score is Greater than or equal to 10&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;In addition to Lorazepam taper:&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="AHS OS N MULTI PCHS Alcohol Withdrawal Protocol Order Set">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patient Care">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="POCT Glucose">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e8da34ee-6e55-438b-ba29-8a6c15655d40" concept_name="LABPOCT Glucose Meter POCT [POC117] Order" max="1" path="/items" name="Glucose Meter POCT"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patient Care Assessments">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="cd975cc8-5ba8-41b4-b6f4-5c923900b655" concept_name="NURAX Clinical Institute Withdrawal Assessment [NUR446] IP Order" max="1" path="/items" name="Clinical Institute Withdrawal Assessment"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Notify">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="NURCOM Notify Most Responsible Health Practitioner (MRHP) [NUR183] IP Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP)"/>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Fluids/Electrolytes">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="IV Fluid Infusions">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9ef28ba-22e1-4bac-aa9a-e6b3a4172eff" concept_name="PHARM SODIUM CHLORIDE 0.9 Percent INTRAVENOUS SOLUTION [27838] Order" max="1" path="/items" name="sodium chloride 0.9% bag"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="295a233b-429a-4871-864a-37589a4d16ee" concept_name="PHARM LACTATED RINGERS INTRAVENOUS SOLUTION [4318] Order" max="1" path="/items" name="lactated Ringer&apos;s infusion"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="24fc5d56-95fe-4de8-8ce0-e439da2e7acc" concept_name="PHARM DEXTROSE 5 Percent AND 0.9 Percent SODIUM CHLORIDE INTRAVENOUS SOLUTION [9815] Order" max="1" path="/items" name="D5-NaCl 0.9% infusion bag"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="035b0056-ec67-41b3-929a-5e8da8be6a19" concept_name="PHARM DEXTROSE 5 Percent AND 0.45 Percent SODIUM CHLORIDE INTRAVENOUS SOLUTION [9814] Order" max="1" path="/items" name="dextrose 5%-sodium chloride 0.45% infusion"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e6c2f7d6-521f-48e8-a779-591cfc76a637" concept_name="PHARM DEXTROSE 5 Percent AND LACTATED RINGERS INTRAVENOUS SOLUTION [9788] Order" max="1" path="/items" name="dextrose 5% in lactated Ringer&apos;s bag"/>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Medications">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="For all Patients regardless of CIWA-Ar Score">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Thiamine">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5d249280-a91c-4de9-9565-324dab6fe94e" concept_name="PHARM VITAMIN B1 (THIAMINE) 100 MG TABLET (WRAPPER) [408770038] Order" max="1" path="/items" name="vitamin B1 (thiamine) Tablet; 300mg po daily for 7 days"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d285e213-fe9a-4dbc-af89-687c2f59c1a1" concept_name="PHARM VITAMIN B1 (THIAMINE) IV IM ORDERABLE [4200252] Order" max="1" path="/items" name="vitamin B1 (thiamine) IM; 300mg IM daily for 7 days"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d285e213-fe9a-4dbc-af89-687c2f59c1a1" concept_name="PHARM VITAMIN B1 (THIAMINE) IV IM ORDERABLE [4200252] Order" max="1" path="/items" name="vitamin B1 (thiamine) IV; 30mg IV daily for 7 days"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Multivitamin">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df74176c-9f3b-490c-8acd-d54251397768" concept_name="PHARM MULTIVITAMIN, ADULT TABLET (WRAPPER) [4001765] Order" max="1" path="/items" name="multivitamin, adult tablet; 1 tab po daily for 30 days"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Folic Acid">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c8ddbe43-1c8b-4e60-a0c8-da965dcc87ee" concept_name="PHARM FOLIC ACID 1 MG TABLET [3233] Order" max="1" path="/items" name="folic acid tablet; 1mg po daily x 5 days"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Dimenhydrinate">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="518ff2cd-715c-4eff-99e5-6678da8a95ac" concept_name="PHARM DIMENHYDRINATE 50 MG TABLET [2485] Order" max="1" path="/items" name="dimenhyDRINATE tablet; 25-50mg PO Q4H PRN for nauses/emesis x 5 days"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b3470f1f-dbbe-484a-a690-f8a12001c2f8" concept_name="PHARM DIMENHYDRINATE INJECTION ORDERABLE [4200101] Order" max="1" path="/items" name="dimenhyDRINATE IM; 25-50 mg IM Q4H, PRN for nausea/emesis x 5 days"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b3470f1f-dbbe-484a-a690-f8a12001c2f8" concept_name="PHARM DIMENHYDRINATE INJECTION ORDERABLE [4200101] Order" max="1" path="/items" name="dimenhyDRINATE IV; 25 - 50mg IV Q4H, PRN for nausea/emesis"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="CIWA-Ar Score is Greater than or equal to 10">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Begin Lorazepam taper as follows:">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b989f64-65e2-49d8-af73-d21c9e196404" concept_name="PHARM LORAZEPAM ORAL TABLET ORDERABLE [4200767] Order" max="1" path="/items" name="LORazepam tablet; DAY 1; 2mg PO QID, for 24 hours"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY #1"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b989f64-65e2-49d8-af73-d21c9e196404" concept_name="PHARM LORAZEPAM ORAL TABLET ORDERABLE [4200767] Order" max="1" path="/items" name="LORazepam tablet; DAY 2; 2mg PO TID, for 24 hours"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b989f64-65e2-49d8-af73-d21c9e196404" concept_name="PHARM LORAZEPAM ORAL TABLET ORDERABLE [4200767] Order" max="1" path="/items" name="LORazepam tablet; DAY 3; 2mg PO BID, for 24 hours."/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="FOLLOWED BY #2"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b989f64-65e2-49d8-af73-d21c9e196404" concept_name="PHARM LORAZEPAM ORAL TABLET ORDERABLE [4200767] Order" max="1" path="/items" name="LORazepam tablet; DAY 4; 1mg PO daily, for 24 hours"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="In addition to Lorazepam taper:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b989f64-65e2-49d8-af73-d21c9e196404" concept_name="PHARM LORAZEPAM ORAL TABLET ORDERABLE [4200767] Order" max="1" path="/items" name="LORazepam tablet; 2mg PO Q1H PRN for alcohol withdrawal x 5 days"/>
        </Item>
      </Item>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.quantityorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">22AFA84E6D7935A3623EDFA7C2EB6D65</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>